About Dr. Cong
Dr. Elaine Alice Cong is an Attending Physician at HSS and is board certified in endocrinology, diabetes and metabolism. She specializes in the evaluation and treatment of patients with endocrine conditions with particular interest in bone health.
After receiving her undergraduate degree from Princeton University, Dr. Cong received her medical degree from Einstein College of Medicine. She completed an internal medicine internship and residency at Yale New Haven Hospital and trained as a fellow in endocrinology, diabetes, and metabolism at Columbia University College of Physicians and Surgeons.
During medical school, Dr. Cong received the Edward Weinstein Award for Outstanding Scholarship and Human Commitment. During her fellowship, she received the Endocrine Fellows Foundation Research Grant to investigate problems of thinking and memory in patients with primary hyperparathyroidism, a metabolic bone disease. She has presented at national academic conferences and authored peer-reviewed publications.
Dr. Cong is a member of the Endocrine Society and the American Society for Bone and Mineral Research.
Departments
Endocrinology
Specialized Centers
Osteoporosis and Metabolic Bone Health
Patient Stories
Insurance
This provider is currently in the process of joining the networks of many commercial insurance plans and should show as a participating provider soon.
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Attending Physician, Hospital for Special Surgery
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Affiliations
American Society for Bone and Mineral Research
Endocrine Society
Certification
Diplomate, Endocrinology, Diabetes and Metabolism
Education
Medical: Einstein College of Medicine, 2009
Internship: Yale New Haven Hospital, 2010
Residency: Yale New Haven Hospital, 2012
Fellowship: Columbia University College of Physicians and Surgeons, 2015
State Licensure
Languages
English
For My Patients
Publications by Dr. Cong
Selected Journal Articles
For all publications, please see the PubMed listing.
Selected Books/Chapters
Cong E and Walker MD. Nutrition and skeletal health in other racial/ethnic groups. In: Holick M and Dawson-Hughes B, eds. Nutrition and Bone Health. New York, NY: Humana Press; 2015: Chapter 17
Selected Presentations
Cong E, Walker MD, Sum M, Lazar RM, Gazes Y, Kepley A, Slane K, Zhang C, McMahon DJ, Marshall RS and Silverberg SJ. Primary Hyperparathyroidism: Investigating Mechanisms of Cognitive Dysfunction. Presented at the American Society for Bone and Mineral Research, Seattle, WA, October 2015
Cong E, Jacobs TP and Silverberg SJ. A Case Report: Bisphosphonate Therapy in a Patient with Extensive Osseous Sarcoidosis. Presented at the Endocrine Society Meeting, San Diego, California, March 2015
Cong E, Walker MD, Lazar RM, Gazes Y, Kepley A, Slane K, Zheng C, McMahon DJ, Marshall RS and Silverberg SJ. Primary Hyperparathyroidism: Cognitive Abnormalities and their Reversibility with Treatment. Presented at the Endocrine Fellows Foundation Research Conference, San Antonio, Texas, January 2015
Cong E and Silverberg SJ. A Case Report: A Patient with "Holes in Her Bones." Presented at the Adult Bone and Mineral Working Group, American Society for Bone and Mineral Research, Houston, Texas, September 2014
Walker MD, Nishiyama K, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, Guo E, Silverberg SJ. Low Vitamin D Levels in Primary Hyperparathyroidism Affect Cortical Bone Density and Porosity but not Estimated Bone Stiffness. Presented at the American Society for Bone and Mineral Research Annual Meeting, Houston, Texas, September 2014
Kepley A, Walker MD, Cong E, Zhang C, Lee J, Silverberg SJ. Primary Hyperparathyroidism Not Confounded by Coexisting Vitamin D Deficiency. Presented at the American Society for Bone and Mineral Research AnnualMeeting, Houston, Texas, September 2014
Cong E, Walker MD, Kepley A, Zhang C, McMahon DJ, Silverberg SJ. No Seasonal Variation in 25-Hydroxyvitamin D in Mild Primary Hyperparathyroidism. Presented at the American Society for Bone and Mineral Research Annual Meeting, Houston, Texas, September, 2014
Cong E, Walker MD, Kepley A, Zhang C, McMahon DJ, Silverberg SJ. Vitamin D Deficiency is Less Common in Mild Primary Hyperparathyroidism. Presented at the American Society for Bone and Mineral Research Annual Meeting, Houston, Texas, September 2014
Cong E, Walker MD, Zhang C and Silverberg SJ. Standard Definition of Vitamin D Deficiency Does Not Identify Bone Mineral Density Differences in Mild Primary Hyperparathyroidism. Presented at the American Society for Bone and Mineral Research Annual Meeting, Baltimore, Maryland, October, 2013
Walker MD, Cong E, Chen P, Weber N, Kepley A, Zhang C, McMahon DJ, Lee and Silverberg SJ. Low Vitamin D Levels in Primary Hyperparathyroidism Are Associated with Low Cortical Bone Density at the Radius Independent of PTH. Presented at the American Society for Bone and Mineral Research Annual Meeting, Baltimore, Maryland, October, 2013
Research
Industry Relationships
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of August 22, 2024, Dr. Cong reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.